| 1 |
35039871 | 2‑Cl‑IB‑MECA regulates the proliferative and drug resistance pathways, and facilitates chemosensitivity in pancreatic and liver cancer cell lines. | 2022 Mar |
2 |
| 2 |
35215276 | A3 Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity. | 2022 Jan 28 |
1 |
| 3 |
34660262 | A3 Adenosine and P2X7 Purinergic Receptors as New Targets for an Innovative Pharmacological Therapy of Malignant Pleural Mesothelioma. | 2021 |
1 |
| 4 |
34671996 | Randomised clinical trial: A phase 2 double-blind study of namodenoson in non-alcoholic fatty liver disease and steatohepatitis. | 2021 Dec |
2 |
| 5 |
31714673 | Activation of adenosine A3 receptor inhibits inflammatory cytokine production in colonic mucosa of patients with ulcerative colitis by down-regulating the nuclear factor-kappa B signaling. | 2020 Jan |
1 |
| 6 |
29170977 | Species differences and mechanism of action of A3 adenosine receptor allosteric modulators. | 2018 Mar |
1 |
| 7 |
29309765 | Molecular dissection of the human A3 adenosine receptor coupling with β-arrestin2. | 2018 Feb |
1 |
| 8 |
30292756 | Probing structure-activity relationship in β-arrestin2 recruitment of diversely substituted adenosine derivatives. | 2018 Dec |
2 |
| 9 |
21520073 | P-glycoprotein mediates resistance to A3 adenosine receptor agonist 2-chloro-N6-(3-iodobenzyl)-adenosine-5'-n-methyluronamide in human leukemia cells. | 2012 Feb |
1 |
| 10 |
22878643 | The adenosine A3 receptor agonist Cl-IB-MECA induces cell death through Ca²⁺/ROS-dependent down regulation of ERK and Akt in A172 human glioma cells. | 2012 Dec |
3 |
| 11 |
19161279 | A series of 2,4-disubstituted quinolines as a new class of allosteric enhancers of the adenosine A3 receptor. | 2009 Feb 26 |
1 |
| 12 |
19284749 | Novel 2- and 4-substituted 1H-imidazo[4,5-c]quinolin-4-amine derivatives as allosteric modulators of the A3 adenosine receptor. | 2009 Apr 9 |
1 |
| 13 |
19639281 | Medicinal chemistry of the A3 adenosine receptor: agonists, antagonists, and receptor engineering. | 2009 |
1 |
| 14 |
18059189 | Cl-IB-MECA inhibits human thyroid cancer cell proliferation independently of A3 adenosine receptor activation. | 2008 Feb |
2 |
| 15 |
18079280 | Dual purinergic synaptic transmission in the human enteric nervous system. | 2008 Feb |
2 |
| 16 |
16051194 | A novel adenosine analog, thio-Cl-IB-MECA, induces G0/G1 cell cycle arrest and apoptosis in human promyelocytic leukemia HL-60 cells. | 2005 Sep 15 |
1 |